Adaptive Biotechnologies Corp reports results for the quarter ended September 30 - Earnings Summary

Adaptive Biotechnologies

08/11/2024 21:07

* Adaptive Biotechnologies Corp  ADPT.OQ  reported a
quarterly
adjusted loss of 22 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of -35 cents.  The mean expectation of
eight analysts for the quarter was for a loss of 29 cents per
share. Wall Street expected results to range from -35 cents
to -24 cents per share.
    * Revenue rose 22.5% to $46.44 million from a year ago;
analysts
expected $40.21 million. 
    * Adaptive Biotechnologies Corp's reported EPS for the
quarter was
a loss of 22 cents​.
    * The company reported a quarterly loss of $32.05 million.
    * Adaptive Biotechnologies Corp shares had risen by 10.0%
this
quarter and gained 14.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.4%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Adaptive
Biotechnologies Corp is $7.00 
This summary was machine generated from LSEG data November 8 at
09:06 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.29          -0.22          Beat
 Jun. 30 2024      -0.33          -0.31          Beat
 Mar. 31 2024      -0.34          -0.33          Beat
 Dec. 31 2023      -0.33          -0.30          Beat